Garmin Lowers Inventory Risk and 4 Stock Analyses to Eye

Heartware International Inc. (NASDAQ:HTWR): After it had discussions with cardiac surgeons and cardiologists, Wells Fargo has reported that the majority of the doctors weren’t worried about the stroke warning on HeartWare’s instructions for use, but a few made cautious comments. The firm thinks that the enthusiasm among doctors for the company’s ventricular assist devices have to potential to continue to be high, but it keeps its Market Perform rating on the stock.

Five Star Quality Care, Inc. (AMEX:FVE): Due to recent weakness, Noble Financial recommends buying Five Star Quality, and the firm believes that shares have the potential to be driven higher long-term as a result of better than expected operating results and multiple expansion. Shares have a Buy rating and a $8 price target.

Teva Pharmaceutical Industries Limited (NASDAQ:TEVA): Cowen thinks that investors should add to their Teva positions because of management expectations of cost benefits from restructuring, cash generation from generic divisions, and current valuation. Shares have an Outperform rating.

Synopsys Inc. (NASDAQ:SNPS) FY13 guidance is believed by DA Davidson to have the potential to provide a catalyst for the stock, and the firm keeps its Buy rating and its $38 price target on the stock.

Garmin Ltd. (NASDAQ:GRMN): According to Pacific Crest’s checks, there are strong PND shipments for Garmin with moderate replenishment, which reduces inventory risk for the March quarter. The firm added that new F10 demand exceeded expectation, and the firm still recommends shares. The stock has an Outperform rating.